Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 2

Sponsor Class

NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 24Lymphoma 13Leukemia 13Lymphoma, Follicular 12Rectal Neoplasms 10Prostatic Neoplasms 10Colonic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Colorectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Congenital Abnormalities 7Ovarian Neoplasms 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myeloid, Acute 6Kidney Neoplasms 6Carcinoma, Ovarian Epithelial 6Burkitt Lymphoma 6Neuroblastoma 5Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Central Nervous System Neoplasms 5Adenocarcinoma of Lung 5

Interventions

Temozolomide 13Carboplatin 12Filgrastim 9Cyclophosphamide 9Vincristine 8Etoposide 8Peripheral Blood Stem Cell Transplantation 7Cisplatin 7Radiotherapy 6Methotrexate 5Magnetic Resonance Spectroscopy 4Thiotepa 3O(6)-benzylguanine 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3Donepezil 3etoposide phosphate 2Vorinostat 2Topotecan 2Psychiatric Rehabilitation 2Paclitaxel 2Leucovorin 2Gadolinium DTPA 2Erlotinib Hydrochloride 2Cyproheptadine 2Carmustine 2Bortezomib 2Amplified Fragment Length Polymorphism Analysis 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Choroid Plexus Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT00360854 2013-09-20

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

National Cancer Institute (NCI)

Phase 1 Unknown
48 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma

NCT00757614 2013-08-26

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

National Cancer Institute (NCI)

Unknown
14,000 enrolled
CNSDermatologicGastrointestinalGenitourinaryLymphoidOther hematologic neoplasm

Uveal Melanoma, Astrocytoma, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Renal Cell, Craniopharyngioma, Esophageal Neoplasms, Hodgkin Disease, Kidney Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Meningeal Neoplasms, Neoplasms, Germ Cell and Embryonal, Pancreatic Neoplasms, Pinealoma, Lymphoma, T-Cell, Cutaneous, Lymphoma, AIDS-Related, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Nephroma, Mesoblastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡